Identifying, building and investing in life science startups
What we do
We identify, build and invest in innovative startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment.
“Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.”
Managing Partner, Seed Investments
We provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.
We focus on company creation and building biotech startups in the Nordic region. Seed Investments aims to develop strong and competitive companies that we finance all the way to a commercial exit.
By end of 2022, the Seed Investment portfolio consisted of 40 companies, including 3 new companies launched in 2022. The portfolio largely consists of private investments, valued at EUR 403 million at the end of 2022.
Seed Investments key figures
Assets under management by the end of 2022
Number of portfolio companies
Our Seed Investments Portfolio
Meet our team